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Purpose: To compare various techniques of pterygium surgery including bare sclera, 
intraoperative mitomycin C application, conjunctival ﬂ  ap reconstruction, and conjunctival 
autografting technique.
Methods: This study is designed to compare 4 currently used techniques in order to determine 
the complication and recurrence rates after pterygium exision. Included in the study were 77 eyes 
from 60 patients. Bare sclera technique was used to treat 21 primary pterygia;mitomycin C was 
used to treat 20 (16 primary, 4 recurrent) pterygia;18 (17 primary, 1 recurrent) pterygia were 
treated by conjuntival ﬂ  ap reconstruction;and 18 (9 primary, 9 recurrent) pterygia were treated 
by conjunctival autografting technique. All patients who underwent surgery were followed up 
for between 6 months and 2 years.
Results: Eight recurrences (38.09%) were observed in the bare sclera group whereas there were 
5 (25%) recurrences in the mitomycin C group. In the conjunctival ﬂ  ap reconstruction group, 
6 (33.33%) recurrences were detected. In the conjunctival autografting group, 3 recurrences were 
observed. There were no major complications threatening visual ability in the surgical patients.
Conclusion: A comparison of the groups demonstrated that the recurrence rate was highest in 
the bare sclera group, and lowest in conjunctival autografting and mitomycin C treatment groups 
respectively. Although the conjunctival autografting technique is a more difﬁ  cult and time consum-
ing technique than the others, cosmetic and surgical results were found to be superior. We advise 
conjunctival autografting for the treatment of pterygium in view of the high recurrence rates of 
other techniques, and the possible complications of mitomycin C treatment for benign disease.
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Introduction
Pterygium is a growth of ﬁ  brovascular tissue on the cornea, which appears to be 
continuous with the conjunctiva.1 Prevalence rates range from 0.7% to 31% in various 
populations around the world, and the condition is more common in warm, dry climates.2 
Treatment of pterygium is surgical. In general, conservative therapy for pterygium is 
warranted unless one of the following circumstances arises: loss of visual acuity either 
because of induced astigmatism or encroachment onto the visual axis, marked cosmetic 
deformity, marked discomfort and irritation unrelieved by medical management, limita-
tion of ocular motility secondary to restriction, or documented progressive growth toward 
the visual axis so that ultimate loss of vision can reasonably be assumed. In such circum-
stances, surgical intervention is required. Because recurrences after pterygia excision are 
frequent and aggressive, ﬁ  rm indications for surgical removal should exist before primary 
excision. The fact that numerous different techniques exist for the surgical treatment of 
pterygium underscores the point that no single approach is universally successful.3 The 
purpose of this study is to compare the four currently used techniques.
Materials and methods
Of the 60 patients who were underwent surgery for pterygium at the Ophthalmol-
ogy Clinic, Zonguldak Karaelmas University Faculty of Medicine, between February Clinical Ophthalmology 2009:3 70
Alpay et al
2001 and October 2004. Seventy-seven eyes were examined 
retrospectively. Patients were categorized in four groups accord-
ing to the type of operation: 42 male and 35 female patients 
were included in the study. The patient’s ages ranged from 22 
to 72 years and their average age was 46.4 ± 2.7 years.
Surgical excision with bare sclera technique was 
performed on 21 eyes (27.27%). Intraoperative mitomycin C 
was applied to 20 eyes (25.97%) after surgical excision. Bare 
sclera was repaired using the conjunctival ﬂ  ap technique, 
after surgical excision in 18 eyes (23.37%). After surgical 
excision, the conjunctival autografting technique was used to 
treat 18 eyes (23.37%);63 primary and 14 recurrent pterygia 
were detected (Table 1).
Before surgery, the best-corrected Snellen visual 
acuity, intraocular pressure (by Goldmann applanation 
tonometry), and details of slit-lamp and fundus examina-
tions were recorded. The mean size of pterygia was 3 mm 
(range, 2–4 mm). There were no differences in mean size 
between the four groups. Surgical procedures were performed 
under local anesthesia using an operation microscope by a 
single surgeon. A speculum was applied to the eye after 
local anesthetic agent application. The area surrounding 
the conjunctival part of the pterygium was marked with 
a marker pen, and 0.5 mL of local anesthetic lidocaine 
HCL 20 mg/mL + epinephrine 0.0125 mg/mL was injected 
under the pterygium body with a 25-gauge neddle. A crescent 
blade was used to excise the corneal part of the pterygium. 
The excision was started from the 0.5 cm transparent cornea 
through the limbus constituting a regular plane. As the limbus 
passed, pterygium was extracted with the tenon under the 
body using a pair of wescot scissors with attention to the 
marked area.
When the bare sclera technique was used after pterygium 
excision, the eyes were closed with a rondel after the 
application of antibiotic ointment.
Pterygium excision was performed on the intraoperative 
mitomycin C group in the way described above. After bare 
sclera excision, a cellulose sponge 3 mm × 4 mm containing 
0.2 mg/mL mitomycin C was applied directly to the scleral 
bed, 2 mm from the limbus for 2 minutes. We took great care 
not bring mitomycin C into contact with the cornea while the 
sponge was in the cap. The sponge was taken out of the cap 
after 2 minutes. The area was irrigated with 200 mL of normal 
saline solution to clear mitomycin C residues. The conjunctiva 
was closed together with a size 8/0 vicryl suture, leaving a 
4-mm bare sclera. Afterwards the eye of the patient was closed 
with a rondell after the application of antibiotic ointment.
Complete resection of the pterygium body and Tenon’s 
capsule was performed using the conjunctival ﬂ  ap technique. 
The conjuctival ﬂ  ap was subsequently made from the superior 
conjunctiva near the limbus. The ﬂ  ap was then thinly dissected, 
avoiding the Tenon’s capsule, and carefully transposed to the 
pterygium excision site. The ﬂ  ap was secured to the adjacent 
conjunctiva with a running suture of 8-0 vicryl. The cut edges 
of the conjunctiva on the donor site were pulled to cover the 
bare sclera and anchored in the limbus with 8–0 vicryl.
In conjunctival autografting, the pterygium was extracted 
as described above, and the dimensions of bare sclera was 
measured. Superior temporal conjunctiva of the same eye, 
approximately 1 mm greater than bare sclera size, was 
Table 1 Demographic characteristic of patients
Treatment procedure Bare sclera Mitomycin Conjunctival ﬂ  ap Autograft Total
Age (mean) Primer 23–68 
(46.42)
Total 22–68 
(46.05)
Total 27–72 
(51.58)
Total 23–65 
(46.22)
Total 22–72 
(48.33)
Total
Recurrent – 23–68 
(46.42)
38–49 
(45.50)
22–68 
(47.95)
50 
(50.00)
27–72 
(51.50)
39–66 
(49.55)
23–66 
(47.88)
38–66 
(48.42)
22–77 
(48.35)
Male 12 12 6 12 42
Female 9 8 12 6 35
Primer Eye 21 16 17 9 63
Pterygia Recurrence 8 (38.09%) 2 (12.50%) 5 (29.41%) 5 (29.41%) 15 (23.80%)
Recurren Eye 0 4 1 9 14
Pterygia Recurrence 0 3 (75%) 1 (100%) 3 (33.33%) 7 (50%)
Total recurrence 
rate
8 (38.09%) 5 (25%) 6 (33.33%) 3 (16.6%) 22 (28.57%)
Recurrence
time (month)
4 4 3 4 Mean: 3.75Clinical Ophthalmology 2009:3 71
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measured and marked (Figure 1). The area under the marked 
space was inﬂ  ated with lidocaine. The aim of this procedure 
was to ease the dissection of the conjunctiva from the tenon 
during autografting, and to obtain the thinnest possible 
conjunctiva. Afterwards, it was dissected as thinly as possible 
from the underlying adhesions. During the incising process 
we paid close attention to leaving the marked area within the 
autograft. In due course the autograft was freed by cutting 
the limbal edge of the conjunctiva (Figure 2). The autograft 
was ﬂ  attened in place, and transferred to the receiver area 
by handling from the two limbal edges (Figure 3). The 
limbal side of the autograft was placed on the limbal area 
in the receiver area. As the autograft regularly ﬂ  attened, it 
was sutured to the adjacent conjunctiva with continuous 
sutures and ﬁ  xed to sclera at the limbus level (Figure 4). The 
autograft was sutured around the adjacent conjunctiva, and 
the eye closed with a rondell after application of antibiotic 
ointment application.
All cases were outpatients. Steroid and antibiotic drops 
were prescribed 4 × per day to all patients after surgery. 
Patients were examined from the ﬁ  rst postoperative day, 
then 1 week, 15 days and 1 month after surgery. Follow-up 
examinations were performed at 3-month intervals subse-
quently. Follow-up periods were between 6 months and 
24 months. The criterion for recurrence was determined 
to be the invasion of cornea more than 1 mm in diameter 
beginning from the limbus by ﬁ  brovascular tissue derived 
from the operation site.4–6
The data obtained were evaluated by SPSS for 
Windows 11.0 programme (SPSS Inc., Chicago, IL, USA). 
Mean values were shown as arithmetical mean value ± 
standard error. Q square test, Fisher’s exact q square test, 
and Kruskal-Wallis analysis of variance were used to 
compare groups. Results of the analysis were evaluated at 
95% conﬁ  dence interval.
Results
In our study we excised the pterygia in 77 eyes of 60 patients. 
Recurrence was observed in 22 cases, with an overall rate 
of 28%. The pterygium was primary in all cases treated by 
the bare sclera method. A case of postoperative bacterial 
conjunctivitis was managed successfully in one week by 
administering antibiotic drops frequently and adding an 
antibiotic ointment twice a day to the treatment. Of 21 cases 
treated with bare sclera technique, 8 (38.09%) experi-
enced recurrence. Two of these patients were treated by 
mitomycin C and the other two by autografting technique. 
Because one of the mitomycin C patients suffered a further 
recurrence, autografting was the procedure of choice for a 
ﬁ  nal operation. Mitomycin C was used on 20 patients, 16 of 
whom were primary and the rest were recurrent;ﬁ  ve cases 
(25%) experienced recurrence, two (12%) of which were 
primary and the other three (75%) were recurrent. Recur-
rent pterygia were treated by conjunctival autografting in 
two patients and with the conjunctival ﬂ  ap technique in 
one case. Conjunctival ﬂ  ap was performed in 18 cases, 
17 of which were primary pterygia. The most common and 
persistent complaint was hyperemia at the operation site, 
which decreased and was resolved over a 2-month period. 
Recurrences were diagnosed in six (33.3%) patients within 
three months. Five of these patients were primary and one 
was recurrent pterygium. Conjunctival autografting was 
practised on nine primary and nine recurrent pterygia. 
Postoperative autograft edema was observed in three patients 
Figure 1 Marking of donor conjunctival site. Figure 2 Removal of donor conjunctival graft.Clinical Ophthalmology 2009:3 72
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and was eliminated by topical steroid administeration, with 
an interval of 2 hours in 1 week. Three (16.6%) patients 
developed recurrences within an average of 4 months. 
Three (33.3%) of these cases were recurrent pterygia. No 
recurrence was seen in primary pterygia. Comparing the 
operation groups revealed that recurrence was highest 
in the bare sclera technique group and lowest in the 
conjunctival autografting group, with rates of 38.09% and 
16.6%, respectively. 63 primary and 14 recurrent pterygia 
underwent surgery. 15 (23%) primary pterygia experienced 
recurrence whereas 7 (50%) recurrent pterygia developed 
recurrence (Table 1). Recurrences were determined within 
2–9 months after pterygia excision. Most recurrences were 
detected in 3–5 months. The mean recurrence periods of the 
various groups were: 4 months for bare sclera, 4 months for 
mitomycin C, 3 months for conjunctival ﬂ  ap technique, and 
4 months for conjunctival autografting (Table 1). The ages of 
the patients included in the study were: 4 patients 20–29 years, 
13 patients 30–39 years, 16 patients 40–49 years, 21 patients 
50–59 years, and 13 patients 60 years and older (Table 2). 
Recurrence was higher in the 40–49 years group. However 
no statistically signiﬁ  cant difference was found between 
the groups (P = 0.303). The most common postoperative 
complaint was irritation followed by photophobia, wetting, 
foreign body sensation, and hyperemia. Irritation was seen 
after the use of suturing techniques, for example in patients 
in the conjunctival ﬂ  ap and conjunctival autografting groups. 
To try and prevent these complaints, eyes were kept shut on 
the postoperative ﬁ  rst day. In response to patient complaints, 
artiﬁ  cial tear drops were prescribed. No major complica-
tion threatening visual ability was encountered among the 
surgical patient groups.
Discussion
The recurrence of pterygium after surgical treatment 
remains a problem. Because of the difﬁ  culty of controlling 
this condition, various treatment modalities including 
radiotherapy, antimetabolite or antineoplastic drugs, 
conjunctival ﬂ  ap, and conjunctival or limbal autograft 
transplantation have been proposed.6 Generally, pterygium 
recurrences occur during the ﬁ  rst 6 months after the sur-
gery.7 A number of factors such as type of pterygium, age 
of patient, environment, and surgical technique may be 
responsible.6
Figure 3 Transfer of graft to recipient area.
Figure 4 Suturing of graft to the excised pterygium side with 8/0 vicryl suture.Clinical Ophthalmology 2009:3 73
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Demireller and colleagues reported 8 (42%) recurrences 
in 19 eyes treated by bare sclera technique.8 Youngson 
declared the pterygium recurrence rate as 37% in 100 cases 
with the same technique, and concluded that this process is 
unhealthy and should not be used.9 Recurrence developed in 
8 (38.09%) of 21 cases in our series treated with excision and 
bare sclera technique. This technique is not recommended 
worldwide because it has no advantages other than being 
simple and time-saving.
Mitomycin C is an antibiotic isolated from Streptomyces 
caespitosis. It inhibits RNA, DNA, and protein synthesis and 
is usually used in systemic anticancer therapy. Kunitomo 
and Mori ﬁ  rst described the topical use of mitomycin C to 
prevent pterygium recurrence in 1963 in Japan.7 Various 
concentrations of mitomycin C with different durations 
of application have been used, but the minimal safe and 
effective dosage and application time are still not certain.10 
Rubinfeld and colleagues revealed reports of scleral ulcer-
ation, necrotizing scleritis, perforation, iridocyclitis, cataract, 
infection, glaucoma, scleral calciﬁ  cation, and loss of an 
eye after pterygium excision with adjunctive mitomycin C 
therapy. While the exact incidence of these complications 
is unknown, the safety of mitomycin C therapy remains to 
be determined with future long-term trials.11 After surgical 
excision, placing mitomycin C is a simple and time-saving 
method with a low recurrence rate. Nevertheless it has some 
dose-dependent complications, which can develop at any 
time. Patients should be followed up for a long time.
Rotational conjunctival ﬂ  aps to cover the pterygium 
excisional site have been employed since the 1940s.3 The 
reported recurrence rates range from less than 1% to more 
than 5%. Minimal to no complications apart from ﬂ  ap retrac-
tion and cyst formation have been reported.12 McCoombes 
and colleagues recently reported a recurrence rate of 3.2% 
by using a sliding conjunctival ﬂ  ap after primary pterygium 
excision in 258 eyes with an 86% follow-up rate for a 
minimum of 1 year.13 In our study, we followed up 18 pte-
rygia patients treated with a ﬂ  ap technique within a period of 
6–20 months;the recurrence rate was detected to be 33.33%. 
There were no serious complications in these cases. The most 
frequent symptom after this procedure was the formation of 
folds over the conjunctiva as a result of rotated tissues in the 
sliding ﬂ  ap area. Although these folds cause bad cosmesis, 
including hyperemia at the begining, after a time the conjunc-
tiva improves and reaches an acceptable level cosmetically. 
Conjunctival ﬂ  ap tissue that is placed over bare sclera is 
adjacent to the excised pterygium tissue, and changed limbal 
cells that might be localised on the ﬂ  ap could contribute to 
the development of recurrence.
Conjunctival autograft transplantation was ﬁ  rst described 
as a treatment for pterygium by Kenyon and colleagues in 
1985.14 Starc and colleagues used this method on 57 eyes of 
54 patients, nearly 80% of which were recurrent. The mean 
follow-up of 2 years detected only three (5.3%) recurrences 
after autograft transplantation and found a 7.3% secondary 
recurrence in patients with recurrent pterygium.15 Güler and 
colleagues observed all of recurrent cases (13.3%), which 
were followed up after autograft transplantation, in the under 
40 year age group (16). These results suggest that the recur-
rence rate was highest in the 40–50 year age group (42.30%) 
in our series. There was no statistically signiﬁ  cant difference 
between groups younger or older than 40 years. Starck and 
colleagues proposed that the efﬁ  cient size of the autograft 
decreases the recurrence rate and this thesis is supported 
by Allan and colleagues.15,17 We have detected recurrence 
in 3 (16.65%) of 18 cases treated with autografting in our 
series. All recurrent cases had previously undergone surgery. 
There was no recurrence after primary pterygia. In recurrent 
pterygium cases, the recurrence rate was found to be signiﬁ  -
cantly high despite autografting. The cause was considered 
to be the incomplete excision of pathological tissues due to 
ﬁ  brosis. The ﬁ  rst 4–6 month period following surgery, agreed 
on by all authors in case of recurrence, is shorter than the 
follow-up period of our study. Some authors prefer lower 
bulbus conjunctiva for autografting, considering that an 
autograft from superior bulbar conjunctiva might cause prob-
lems in probable ﬁ  ltration surgery.18 Syam and colleagues 
reported a recurrence rate of 3.3% in a study of 27 eyes. 
Recurrences were found to develop within 3 months after 
surgery. Conjunctival scar was reported to be 36.66% in the 
donor area. Hemorrhage under the autograft, corneal delen 
near the limbus, and epithelial inclusion cysts were reported 
in 3, 4, and 2 eyes, respectively.19 Koç and colleagues 
demonstrated that autografting from superior or inferior in 
primary cases caused no signiﬁ  cant difference in recurrence, 
but in recurrent pterygia, autografting from inferior resulted 
in a higher recurrence tendency (p = 0.166).20 In our study, 
Table 2 Recurrence distribution with respect to age groups
Age distrubition Eye Recurrence %
20–29 4 0
30–39 13 3 23.07
40–49 26 11 42.30
50–59 21 5 23.80
60 13 3 23.07Clinical Ophthalmology 2009:3 74
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graft tissue was gathered from the superior temporal region 
because of the possibility of a ﬁ  ltran surgery. Complications 
resulting from conjunctival autografting are rare and are no 
threat to vision. Allan and colleagues encountered one tenon 
granuloma, one conjunctival inclusion cyst, and three 
wound dehissence in a series of 93 cases, and concluded 
that the conjunctival autografting technique results in lower 
complication rates.17 All these complications were eliminated 
by minor surgical interventions. Vrabek and colleagues 
reported subconjunctival ﬁ  brosis at the autografting region in 
2 cases, one of whom developed concommitant diplopia due 
to extraocular muscle restriction.21 Topical corticosteroids 
were suggested in order to prevent ﬁ  brosis. In most studies 
of autografting, retrobulber anesthesia was performed, which 
was reported to be one of the disadvantages of this technique. 
In our study, we have not determined any complications due 
to subconjunctival anesthesia;moreover, motions of the eye 
are no hindrance to the surgeon. In some patients, who are 
incapable of controlling eye motions, two traction sutures 
to the limbus at 12 and 6 o’clock were performed in order 
to prevent this problem. The disadvantages of the conjunc-
tival autografting technique could be resolved as follows: a 
long operation time, the need for retrobulber anesthesia in 
some cases, limitation of the autograft diameter from the 
conjunctiva, and can cause problems in a probable ﬁ  tra-
tion surgery. One of the other disadvantages of suturing is 
postoperative pricking. This effect might be minimized by 
placing the knot under the conjunctiva or using continuous 
suturing. In spite of all these difﬁ  culties, the recurrence rate 
is lower with this technique. After the operation, a smooth, 
white surface is achieved cosmetically. The disadvantage 
of the long operation time becomes an advantage with a 
low recurrence rate and no need for additional surgical 
intervention. As these are the most desired aims of surgery, 
the conjunctival autografting technique therefore deserves 
clear recognition.
In conclusion, according to this study we recommend 
that even in treating primary pterygium, additional methods 
should be used. When possible complications and morbidity 
are taken into account in the selection of this additional 
method, conjunctival autografting may be preferred.
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